Home The Decentralised procedure used for the registration of ROVIs biosimilar of enoxaparin has been completed with positive outcome

The Decentralised procedure used for the registration of ROVIs biosimilar of enoxaparin has been completed with positive outcome

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact
Read time: 0 mins
The Decentralised procedure used for the registration of ROVIs biosimilar of enoxaparin has been completed with positive outcome
https://www.rovi.es/sites/default/files/The%20Decentralised%20procedure%20used%20for%20the%20registration%20of%20ROVIs%20biosimilar%20of%20enoxaparin%20has%20been%20completed%20with%20positive%20outcome.%2807-03-2017%29.pdf
Year: 
2017